Australian Idiopathic Pulmonary Fibrosis Registry clinical trials now recruiting
One of the aims of the Australian Idiopathic Pulmonary Fibrosis (IPF) Registry is to maximise recruitment into IPF clinical trials, thereby supporting the development of novel therapies. Currently, a number of IPF clinical trials are planned that will offer anti-fibrotic medication in both their placebo and active arm. In addition, there are a number of current IPF clinical trials recruiting in Australia including the following:
Other clinical trials have completed their recruitment and details of these can be found on the Lung Foundation website at https://lungfoundation.com.au/patient-support/other-lung-conditions/idiopathic-pulmonary-fibrosis-ipf/. If you are interested in participating in a clinical trial, do stay in touch with your respiratory physician.
If you have IPF, please ask your respiratory physician about the Australian IPF Registry during your next visit. Health professionals please contact the registry coordinator in your state to let them know of your IPF patients who are interested in joining the registry.
To find the coordinator in your state, please call Sacha Macansh on 02 9515 3996 or email email@example.com or visit the Lung Foundation Australia website https://lungfoundation.com.au/health-professionals/idiopathic-pulmonary-fibrosis-registry/.